In the CCl<sub>4</sub> model, P49-PROTAC<sup>VHL</sup> attenuated liver fibrosis, as evidenced by reduced collagen deposition, decreased α-SMA expression, and improved liver function. Here, VHL is linked to Hepatic fibrosis.